Comparative Antioxidant Profiling of Wild and Cultivated Taihangia rupestris

Study Background and Research Question

Diabetes mellitus and its complications remain a major challenge in global health, partly due to the limitations and side effects of current pharmacological treatments. Reactive oxygen species (ROS) are implicated in the pathogenesis and progression of diabetic complications, while a-glucosidase inhibitors (a-GIs) are recognized for their role in controlling postprandial hyperglycemia and related metabolic disorders. Taihangia rupestris Yu & Li (T. rupestris), a nationally protected plant in China, has a history of use in traditional medicine for diabetes management and other indications. However, the scarcity of wild T. rupestris and the lack of comprehensive phytochemical and pharmacological comparison between wild and cultivated forms have limited its broader pharmaceutical application.

Key Innovation from the Reference Study

The reference study (RSC Adv., 2026, 16, 28230) delivers a systematic, side-by-side analysis of the chemical composition and bioactivity profiles of wild, mountain-cultivated, and foothill-cultivated T. rupestris leaves. The innovation lies in combining high-resolution UPLC-MS/MS metabolomics with comprehensive in vitro antioxidant and a-glucosidase inhibition assays, thereby identifying not only the qualitative and quantitative differences in phytochemicals but also the functional consequences for antidiabetic activity. The study further integrates advanced screening tools—such as UF-LC/MS and molecular docking—to pinpoint specific antioxidant and a-GI compounds and elucidate their interaction mechanisms.

Methods and Experimental Design Insights

The experimental workflow adopted a multi-tiered approach:

• Sample Collection: Leaves were harvested from wild T. rupestris and two cultivated populations (mountain, foothill) to represent distinct ecological conditions.
• UPLC-MS/MS Profiling: Ultra-performance liquid chromatography coupled with tandem mass spectrometry (UPLC-MS/MS) was used for comprehensive metabolite identification and quantification, enabling high-resolution discrimination of 114 compounds among sample groups.
• Antioxidant Capacity Evaluation: Four complementary in vitro assays were conducted—ferric reducing antioxidant power (FRAP), cupric reducing antioxidant capacity (CUPRAC), total reducing capacity (TRC), and the DPPH (2,2-Diphenyl-1-Picrylhydrazyl) radical scavenging assay.
• a-Glucosidase Inhibitory Activity: Inhibition was quantified via IC₅₀ values, benchmarked against standard inhibitors.
• Active Compound Screening: Online HPLC-ABTS and ultrafiltration-LC/MS (UF-LC/MS) were employed for rapid antioxidant and a-GI screening, with molecular docking elucidating binding interactions.

Protocol Parameters

• DPPH Assay: Typically performed using DPPH dissolved in ethanol (≥13.13 mg/mL with sonication), measuring absorbance decrease at 515–528 nm to quantify radical scavenging. Freshly prepared solutions are recommended due to DPPH's limited solution stability (product information).
• Sample Extract Concentrations: Activity observed across low micromolar to higher ranges; optimal concentrations determined empirically based on extract potency and assay format.
• UPLC-MS/MS Settings: High-resolution mass spectrometry with untargeted metabolomics workflows enables broad-spectrum compound annotation.
• a-Glucosidase Assay: Extracts tested for inhibitory effect; IC₅₀ calculated using standard dose-response curves.

Core Findings and Why They Matter

Among the 114 identified compounds, 111 exhibited significant environment-dependent variation, with flavonoids, phenolics, and terpenoids as the dominant classes. Notably, foothill-cultivated T. rupestris leaves demonstrated elevated levels of key bioactives (e.g., rutin, gallic acid derivatives; P < 0.05) and surpassed both wild and mountain-cultivated plants in functional assays:

• Antioxidant Activity: Foothill-cultivated samples showed higher Trolox equivalents in FRAP (367.18 ± 1.03) and CUPRAC (572.40 ± 0.82) assays, consistent with superior DPPH radical scavenging capacity.
• a-Glucosidase Inhibition: Foothill-cultivated extracts had the lowest IC₅₀ (0.2775 mg/mL), outperforming wild (0.4948 mg/mL) and mountain-cultivated (0.5425 mg/mL) samples.
• Active Compounds: Ten antioxidants were identified, with seven also acting as a-GIs. UF-LC/MS and molecular docking confirmed eight potent a-GIs, demonstrating hydrogen bond formation with ASP residues in the enzyme active site.

These results indicate that artificial cultivation, particularly under foothill conditions, not only conserves T. rupestris as a resource but also enhances its content of bioactive compounds relevant to diabetes intervention. The dual antioxidant and a-GI activities suggest multi-target therapeutic potential, supporting further investigation into its translational value against diabetic complications (study details).

Comparison with Existing Internal Articles

The findings align with and extend insights from previous comparative analyses. For example, internal research also highlights the superior antioxidant and enzyme-inhibitory activities of cultivated T. rupestris. Moreover, several workflow-focused articles such as DPPH Radical Assay: Advanced Workflows for Antioxidant Screening and DPPH Radical Assay: Advancing In Vitro Antioxidant Screening provide practical guidance on optimizing DPPH-based antioxidant assays for natural product extracts. These resources emphasize the utility of DPPH (2,2-Diphenyl-1-Picrylhydrazyl) as a rapid, quantitative readout for high-throughput antioxidant screening, as well as the importance of integrating multiple colorimetric and biochemical assays to robustly characterize functional activity in plant-derived materials.

Limitations and Transferability

Despite the comprehensive metabolomic and bioactivity profiling, the study's outcomes are bounded by several factors. In vitro antioxidant screening and a-glucosidase inhibition provide valuable mechanistic insight, but do not directly predict in vivo efficacy or pharmacokinetics. Environmental variables such as soil composition, microclimate, and cultivation practices may further influence metabolite profiles, limiting the direct extrapolation to other medicinal plant systems. Additionally, while molecular docking supports potential binding mechanisms, experimental validation in cellular or animal models is needed to confirm therapeutic potential and safety profiles.

Research Support Resources

For researchers aiming to replicate or extend these workflows, the DPPH (2,2-Diphenyl-1-Picrylhydrazyl) Radical (SKU C3691) from APExBIO provides a highly reproducible reagent for colorimetric antioxidant assays, supporting both high-throughput and targeted biochemical evaluation of natural products. Its well-characterized protocol compatibility and rapid visual readout make it suitable for screening antioxidant and radical scavenging activities in plant extracts or compound libraries.